Therapy Areas: Devices
Mauna Kea Technologies announces preliminary sales in EUR2.2m to EUR2.3m range for the Q4 2020
7 January 2021 -

Medical device company Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext:MKEA) disclosed on Wednesday that it expects preliminary sales in a range of EUR2.2m to EUR2.3m for the Q4 2020.

This marks a rise of approximately 30% to 36% year-over-year.

In the Q4 2020, the company anticipates US sales to grow approximately 34% to 38% year-over-year and Rest of World (ROW) sales are expected to escalate by approximately 26% to 33% year-over-year.

For the Q4 2020, the consumables sales are expected to decline approximately 9% to 14% year-over-year; Systems sales are expected to shoot up by approximately 177% to 185% year-over-year; Services sales are expected to decrease approximately 9% to 13% year-over-year.

Login
Username:

Password: